Lupus Clinical Trials in Philadelphia

Showing 121-134 of 134 trials

Effect of Symbicort on Sleep Quality in Patients With Emphysema

NCT01602523

This study will look at the effects of the drug Symbicort on sleep quality. Symbicort is an inhaled medication that contains 2 drugs. One is a medication that opens up the airways (formoterol). The other is a steroid to decrease airway inflammation (budesonide). Symbicort is not an experimental medication. It is approved by the Food and Drug Administration for use in patients with emphysema. Patients with severe emphysema commonly sleep poorly. The cause of poor sleep in these patients is unknown. Symbicort may improve sleep quality by opening the airways and reducing lung inflammation. It is not known for sure if these effects actually improve sleep and quality of life. It is hoped that this study will answer this question.

EmphysemaPoor Sleep Quality

Temple University40 participantsStarted Mar 2011

Philadelphia, Pennsylvania, United States

COMPLETEDPHASE4< 1 mile

Efficacy and Tolerability of Armodafinil in Adults With Excessive Sleepiness Associated With Shift Work Disorder

NCT01080807

The primary objective of the study is to determine whether armodafinil treatment is more effective than placebo treatment in patients with excessive sleepiness associated with shift work disorder (SWD) by measuring improved clinical condition late in the shift, including the commute home.

Excessive Sleepiness

Cephalon385 participantsStarted Mar 2010

Phoenix, Arizona, United States • Tucson, Arizona, United States • Hot Springs, Arkansas, United States +60 more locations

Effect of Symbicort on Sleep Quality in Patients With Emphysema

Efficacy and Tolerability of Armodafinil in Adults With Excessive Sleepiness Associated With Shift Work Disorder

Lupus Trials in Other Cities

PROVIGIL® (Modafinil) Treatment in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy or Obstructive Sleep Apnea/Hypopnea Syndrome

Efficacy and Safety of Zolpidem-MR Administered Over a Long Term Period as Needed for Insomnia (ZOLONG)

Efficacy and Safety of Eplivanserin Treatment for Sleep Maintenance Insomnia Followed by Optional Extension up to 1 Year

Single Dose Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Evaluation of Eplivanserin in Children With Insomnia

To Assess Prevention of Bone Loss in Women With Lupus Receiving Treatment With Glucocorticoids

Study of the Efficacy and Multiple-Dose Plasma Concentration-Time Profiles of Armodafinil and PROVIGIL

Study of Epratuzumab in Systemic Lupus Erythematosus

Efficacy and Safety of Circadin for Non-24 Hour Sleep-Wake Disorder in Totally Blind Subjects

PEARL-SC Trial: A Study of the Efficacy, Safety, and Tolerability of A 623 Administration in Subjects With Systemic Lupus Erythematosus

Etanercept for the Treatment of Lupus Nephritis

Efficacy and Safety of SR46349B in Patients With Sleep Disorders in Fibromyalgia

Feasibility Study to Determine the Effects of Phrenic Nerve Stimulation in Patients With Periodic Breathing

Other Conditions in Philadelphia